Melbourne-Led World-First Clinical Trial May Lead to Type 1 Diabetes Drug Treatment

Researchers at St Vincent’s Institute of Medical Research (SVI) in Melbourne are leading a clinical trial to test a treatment intended to stop the immune system from destroying the insulin-producing cells of people with newly diagnosed type 1 diabetes.